WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Jan 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-12-31

Reporting Person: BUTHMAN MARK A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-31	Phantom Stock Unit	$	A	347.9614	Acquired		Common Stock (347.9614)	Direct

Footnotes

F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.